Naloxone Oral Syringes
Closed Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- W81K00-26-Q-A022
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command, through Brooke Army Medical Center (BAMC), is procuring 1,413 naloxone 2mg/2ml oral syringes annually under a base plus four-year contract (five years total) with a performance period from October 1, 2025 to September 30, 2030. The oral syringes must be packaged with a tamper-evident cap, without a luer lock tip, labeled for oral use only, and maintain a beyond-use date of at least 30 days. The procurement will be evaluated using a lowest price technically acceptable (LPTA) source selection process, where offerors must demonstrate that their product meets essential technical characteristics to receive an "Acceptable" rating and be considered for award. Multiple amendments have extended proposal deadlines, with the most recent extension setting bidder questions due by November 10, 2025, and proposal responses due by November 14, 2025, at 1:00 p.m. CST. All offerors must be registered in the System for Award Management (SAM) and provide their tax identification and CAGE code numbers.
This solicitation (W81K0026QA022) is set aside for Women-Owned Small Business (WOSB) contractors under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The contract requires delivery to the AMC BAMC FSH - MM at Joint Base San Antonio Fort Sam Houston, Texas, with the first delivery due by September 30, 2026, and subsequent annual deliveries through September 30, 2030. The solicitation represents a total procurement of approximately 7,065 units over the five-year contract period, addressing anticipated supply shortages and potential price increases for this critical opioid-overdose reversal medication used by the Inpatient Pharmacy and Burn Unit. Payment will be processed electronically through the Defense Finance and Accounting Service (DFAS) and Wide Area WorkFlow (WAWF). While specific contract value information is not disclosed in the available documents, the government has certified that the anticipated cost is fair and reasonable.
Notice text
3 versions
Update #3 · Latest ·
THE PURPOSE OF SOLICITATION AMENDMENT IS TO EXTEND THE SOLICITATION FOR THE NALOXONE 2MG/2ML ORAL SYRINGES. PLEASE SEE SOLICITATION AMENDMENT LABELLED W81K0026QA0220003.
The Department of Pharmacy at Brooke Army Medical Center (BAMC) is requesting a base plus 4 year (5 years total) contract for 1,413 Naloxone oral syringes annually.
- Bidder Questions Due: 10 November 2025
- Responses Due: 14 November 2025, 1:00 p.m., CST
Update #2 ·
THE PURPOSE OF SOLICITATION AMENDMENT 0001 IS TO EXTEND THE SOLICITATION TO 22 OCTOBER 2025 FOR THE NALOXONE 2MG/2ML ORAL SYRINGES.
The Department of Pharmacy at Brooke Army Medical Center (BAMC) is requesting a base plus 4 year (5 years total) contract for 1,413 Naloxone oral syringes annually.
- Bidder Questions Due: 15 Oct 2025
- Responses Due: 22 Oct 2025, 1:00 p.m., CST
Update #1 ·
The Department of Pharmacy at Brooke Army Medical Center (BAMC) is requesting a base plus 4 year (5 years total) contract for 1,413 naloxone oral syringes annually.
Period of Performance: 01 OCTOBER 2025 to 30 SEPTEMBER 2030
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Naloxone Oral Syringes | Solicitation | |
| This notice | Solicitation | |
| Naloxone Oral Syringes | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity